[Remote] Sr. Director of Alliance Management, Institutional Research Partnerships at Natera

United States

Natera Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Alliance ManagementPartnership ManagementContractingResearch CollaborationsData SharingBiobankingInvestigator-Initiated Studies (IIS)Real-World Evidence (RWE)Stakeholder AlignmentCross-functional CollaborationProject ManagementRisk MitigationClinical Utility StudiesBiomarker DiscoveryPrecision Medicine

Questions & Answers

Common questions about this position

What experience is required for the Sr. Director of Alliance Management role?

Candidates need 7+ years of experience in alliance management, business development, academic/industry partnerships, or clinical research operations, preferably in diagnostics, biopharma, or health.

What are the key responsibilities in alliance strategy and relationship management?

The role involves owning contracting and operational management of research partnerships, serving as the point of contact for key external and internal stakeholders, and ensuring seamless contracting, onboarding, communication, and long-term partner satisfaction through structured engagement and governance models.

Is this a remote position or does it require office presence?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What makes a strong candidate for this position?

A strong candidate will have 7+ years in alliance management, business development, or academic/industry partnerships, preferably in diagnostics or biopharma, with skills in managing research collaborations, stakeholder alignment, and strategic partnership execution.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI